ALICIA RESTIVO: Open Payments
NPI 1356318620 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 13 payments from 8 companies in 2025. Trend: 2023 $526 · 2024 $730 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 4 | $291 |
| Boston Scientific Corporation | 1 | $93 |
| Abbott Laboratories | 1 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| TOLMAR, INC. | 1 | $21 |
| Dexcom, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Xeomin, WATCHMAN FLX, FREESTYLE LIBRE 3, NUZYRA, JATENZO, Dexcom G6 Transmitter, ZEPBOUND, MOUNJARO.
Industry payments across LA — which companies pay providers there.
